183 related articles for article (PubMed ID: 37915129)
1. Group 3 Innate Lymphoid Cells Exacerbate Lupus Nephritis by Promoting B Cell Activation in Kidney Ectopic Lymphoid Structures.
Li F; Liang Z; Zhong H; Hu X; Tang Z; Zhu C; Shen J; Han X; Lin R; Zheng R; Tang R; Peng H; Zheng X; Mo C; Chen P; Wang X; Wen Q; Li J; Xia X; Ye H; Qiu Y; Yu J; Fu D; Liu J; Wang R; Xie H; Guo Y; Li X; Fan J; Liu Q; Mao H; Chen W; Zhou Y
Adv Sci (Weinh); 2023 Dec; 10(35):e2302804. PubMed ID: 37915129
[TBL] [Abstract][Full Text] [Related]
2. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
Chen K; Deng Y; Shang S; Tang L; Li Q; Bai X; Chen X
Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550
[TBL] [Abstract][Full Text] [Related]
3. T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus.
Düster M; Becker M; Gnirck AC; Wunderlich M; Panzer U; Turner JE
Eur J Immunol; 2018 Aug; 48(8):1364-1375. PubMed ID: 29671873
[TBL] [Abstract][Full Text] [Related]
4. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
Su B; Ye H; You X; Ni H; Chen X; Li L
Life Sci; 2018 Sep; 208():26-32. PubMed ID: 30146016
[TBL] [Abstract][Full Text] [Related]
5. Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis.
Oates JC; Halushka PV; Hutchison FN; Ruiz P; Gilkeson GS
Am J Med Sci; 2011 Feb; 341(2):101-5. PubMed ID: 20924284
[TBL] [Abstract][Full Text] [Related]
6. A benzenediamine derivate FC-99 attenuates lupus nephritis in MRL/lpr mice via inhibiting myeloid dendritic cell-secreted BAFF.
Ji J; Xu J; Li F; Li X; Gong W; Song Y; Dou H; Hou Y
Acta Biochim Biophys Sin (Shanghai); 2016 May; 48(5):411-9. PubMed ID: 27121231
[TBL] [Abstract][Full Text] [Related]
7. Renal-infiltrating CD11c
Liao X; Ren J; Reihl A; Pirapakaran T; Sreekumar B; Cecere TE; Reilly CM; Luo XM
Clin Exp Immunol; 2017 Nov; 190(2):187-200. PubMed ID: 28722110
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of FoxO3a expression through PI3K/Akt pathway attenuates the progression of lupus nephritis in MRL/lpr mice.
Zhao C; Gu Y; Chen L; Su X
Int Immunopharmacol; 2020 Dec; 89(Pt A):107027. PubMed ID: 33039957
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse.
Sato S; Zhang XK; Matsuoka N; Sumichika Y; Saito K; Yoshida S; Matsumoto H; Temmoku J; Fujita Y; Asano T; Migita K
Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37094946
[TBL] [Abstract][Full Text] [Related]
10. Pim-1 as a Therapeutic Target in Lupus Nephritis.
Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
[TBL] [Abstract][Full Text] [Related]
11. CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice.
Wu X; Guo J; Ding R; Lv B; Bi L
Acta Histochem; 2015 Oct; 117(8):732-7. PubMed ID: 26456520
[TBL] [Abstract][Full Text] [Related]
12. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
Li X; Liu J; Zhao Y; Xu N; Lv E; Ci C; Li X
BMC Nephrol; 2022 Jul; 23(1):243. PubMed ID: 35804318
[TBL] [Abstract][Full Text] [Related]
13. Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis.
Qi YY; Zhou XJ; Cheng FJ; Hou P; Ren YL; Wang SX; Zhao MH; Yang L; Martinez J; Zhang H
Ann Rheum Dis; 2018 Dec; 77(12):1799-1809. PubMed ID: 30209031
[TBL] [Abstract][Full Text] [Related]
14. CRAC Channel Controls the Differentiation of Pathogenic B Cells in Lupus Nephritis.
Li X; Zeng Q; Wang S; Li M; Chen X; Huang Y; Chen B; Zhou M; Lai Y; Guo C; Zhao S; Zhang H; Yang N
Front Immunol; 2021; 12():779560. PubMed ID: 34745151
[TBL] [Abstract][Full Text] [Related]
15. JAK/STAT signaling controls the fate of CD8
Zhou M; Guo C; Li X; Huang Y; Li M; Zhang T; Zhao S; Wang S; Zhang H; Yang N
J Autoimmun; 2020 May; 109():102424. PubMed ID: 32085893
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
Zhang Z; Liu D; Zhang X; Wang X
Inflammation; 2018 Oct; 41(5):1888-1899. PubMed ID: 29951872
[TBL] [Abstract][Full Text] [Related]
17. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-
Wada Y; Gonzalez-Sanchez HM; Weinmann-Menke J; Iwata Y; Ajay AK; Meineck M; Kelley VR
J Am Soc Nephrol; 2019 Feb; 30(2):244-259. PubMed ID: 30622154
[TBL] [Abstract][Full Text] [Related]
18. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
Sugahara K; Maeda Y; Shimano K; Murase M; Mochiduki S; Takemoto K; Kakimoto T; Utsumi H; Oshita K; Kataoka H
J Immunol Res; 2019; 2019():5821589. PubMed ID: 31930150
[TBL] [Abstract][Full Text] [Related]
19. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
[TBL] [Abstract][Full Text] [Related]
20. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
He J; Sun M; Tian S
Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
